GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Central Pharmaceutical JSC No2 (HSTC:DP2) » Definitions » Debt-to-Revenue

Central Pharmaceutical JSC No2 (HSTC:DP2) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Central Pharmaceutical JSC No2 Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Central Pharmaceutical JSC No2's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Central Pharmaceutical JSC No2's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Central Pharmaceutical JSC No2's annualized Revenue for the quarter that ended in . 20 was ₫0.00 Mil.


Central Pharmaceutical JSC No2 Debt-to-Revenue Historical Data

The historical data trend for Central Pharmaceutical JSC No2's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceutical JSC No2 Debt-to-Revenue Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Debt-to-Revenue

Central Pharmaceutical JSC No2 Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of Central Pharmaceutical JSC No2's Debt-to-Revenue

For the Pharmaceutical Retailers subindustry, Central Pharmaceutical JSC No2's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceutical JSC No2's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Central Pharmaceutical JSC No2's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical JSC No2's Debt-to-Revenue falls into.



Central Pharmaceutical JSC No2 Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Central Pharmaceutical JSC No2's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Central Pharmaceutical JSC No2's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


Central Pharmaceutical JSC No2 Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Central Pharmaceutical JSC No2's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceutical JSC No2 (HSTC:DP2) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.

Central Pharmaceutical JSC No2 (HSTC:DP2) Headlines

No Headlines